List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 550 studies with search of:   vaccines [CONDITION] OR vaccines [TREATMENT] | Open Studies
  Display Options
Rank Status Study
1 Recruiting Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
Conditions: Seasonal Influenza;   Vaccine
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza vaccine
2 Recruiting Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Adults
Condition: Vaccines, Pneumococcal
Interventions: Biological: VACCINE: 13-valent pneumococcal conjugate vaccine;   Biological: VACCINE: placebo
3 Recruiting Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life
Conditions: Meningococcal Infections;   Pneumococcal Infections
Interventions: Biological: NeisVacC (Meningococcal C conjugate vaccine);   Biological: Menjugate (Meningococcal C conjugate vaccine)
4 Recruiting Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old
Condition: Influenza
Interventions: Biological: Trivalent Subunit Influenza Vaccine;   Biological: Trivalent Subunit Influenza Vaccine;   Biological: Trivalent Subunit Influenza Vaccine;   Biological: Egg-derived trivalent subunit influenza vaccine
5 Recruiting Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine;   Biological: pneumococcal polysaccharide vaccine
6 Recruiting The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A (TB vaccine);   Biological: MVA 85A
7 Not yet recruiting Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: Vaccine Vivotif + Vaccine Dukoral + oats;   Biological: Vaccine Vivotif + Vaccine Dukoral;   Dietary Supplement: Oats;   Other: Placebo
8 Recruiting Co-Administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration
Conditions: Meningococcal Disease;   Pneumococcal Disease.
Interventions: Biological: Meningococcal vaccine GSK134612;   Biological: Pneumococcal vaccine GSK1024850A
9 Recruiting Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-Valent)
Condition: Vaccines, Pneumococcal Conjugate Vaccine
Intervention: Biological: Pneumococcal Conjugate Vaccine, 7-valent (Prevenar)
10 Recruiting Study Evaluating the Impact of a 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
Condition: Pneumococcal Infections
Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine;   Biological: 7 valent pneumococcal conjugate vaccine
11 Recruiting Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine
Condition: Influenza Infection
Interventions: Biological: Subunit influenza vaccine;   Biological: Adjuvanted influenza vaccine;   Biological: Adjuvanted influenza vaccine combined with CpG7909;   Biological: Adjuvanted influenza vaccine combine with CpG7909;   Biological: Adjuvanted influenza vaccine combine with CpG7909
12 Recruiting Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Conditions: Breast Cancer;   Lung Cancer;   Prostate Cancer
Interventions: Biological: inactivated influenza vaccine and the 23- valent pneumococcal vaccine;   Biological: inactivated influenza vaccine and the PPV23 vaccine (Pneumovax)
13 Recruiting Phase Ib Trial of MSP3 LSP in Children in Tanzania
Condition: Malaria
Interventions: Biological: MSP 3 Long Synthetic Peptide;   Biological: MSP3 vaccine;   Biological: Hepatitis B vaccine;   Biological: MSP3 candidate vaccine;   Biological: Hepatitis B control vaccine
14 Recruiting Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
Condition: Malaria
Interventions: Biological: GMZ2 (malaria vaccine);   Biological: GMZ2 malaria vaccine;   Biological: Verorab vaccine
15 Not yet recruiting Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants
Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine;   Biological: meningococcal B rLP2086 vaccine;   Biological: meningococcal B rLP2086 vaccine;   Biological: meningococcal B rLP2086 vaccine;   Biological: Routine age appropriate childhood vaccines
16 Recruiting Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
Condition: Meningococcal Meningitis
Interventions: Biological: MenACWY, heptavalent conjugate pneumococcal and DTaP-Hib-HBV-IPV vaccine;   Biological: MenACWY, heptavalent conjugate pneumococcal and DTaP-Hib-HBV-IPV vaccine;   Biological: MenACWY, heptavalent conjugate pneumococcal and DTaP-Hib-HBV-IPV vaccine
17 Recruiting Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
Condition: Influenza
Interventions: Biological: Influenza Trivalent Inactivated vaccines Novartis;   Biological: Influenza Trivalent Inactivated vaccines
18 Recruiting Alpha-Type-1 Dendritic Cell-Based Vaccines in Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Biological: DC-based vaccine;   Biological: DC-based vaccine;   Biological: DC-based vaccine
19 Recruiting Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
20 Recruiting PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Condition: Prostate Cancer
Intervention: Biological: peptide vaccine (PSMA and TARP peptide vaccine with Poly IC-LC adjuvant)

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services